As impaired cytolytic activity of NKs from AML patients had been proposed to be caused by reduced expression of NCRs [25,26], expression of NKp30, NKp44 and NKp46 on enriched NKs was studied (Figure 6). This evidence concerns the gene NCR2 and acute myeloid leukemia.